Monoclonal B lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL) are both characterized by the accumulation of clonal B lymphocytes with a mature phenotype and an abnormal BCR signaling and function in peripheral blood, bone marrow or secondary lymphoid tissues (1, 2). This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.